| 2026-08-21 17:17 |
8-K |
["9.01"] |
merger agreement |
0.95
|
Amendment to 8-K confirming consummated merger between Aptorum (now Niki BioSolutions) and DiamiR effective July 20, 2026. |
SEC · detail |
| 2026-08-21 17:00 |
8-K |
["9.01"] |
other |
0.00
|
Post-closing merger documentation; transaction already consummated July 20, 2026. No forward-looking M&A signal. |
SEC · detail |
| 2026-08-07 16:00 |
8-K |
["8.01"] |
other |
0.05
|
8-K Item 8.01 reports Nasdaq compliance restoration; no M&A signals present. |
SEC · detail |
| 2026-07-20 08:15 |
8-K |
["2.01"] |
merger agreement |
1.00
|
Completed merger: Aptorum (now Niki BioSolutions) acquired DiamiR Biosciences; closed July 20, 2026. |
SEC · detail |